olaparib,abiraterone
astrazeneca,merck,janssen
['crpc', 'propel', 'olaparib']
finally, our paper about propel trial was published in during : abiraterone and olaparib for metastatic crpc | 
Principal Investigator in CIP FUNFARME/FAMERP  
Scientific Director and Medical Oncologist in Medical Oncology Department FUNFARME.